Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...
Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health agencies under Robert F. Kennedy Jr.’s leadership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback